Pregnancy and Postpartum CGM in GDM

Recruiting now

Conditions studied: Gestational Diabetes

In brief

Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.

Key facts

Study ID

NCT07174245

Run by

Icahn School of Medicine at Mount Sinai

People needed

40

Starts

2025-08-05

Expected to finish

2027-07-01

Last updated by the study team

2026-07-08

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of gestational diabetes during current pregnancy
• age 18 or older
• prescribed Dexcom G7

You may not qualify if…

• Pregestational diabetes
• known skin adhesive allergy which inhibits ongoing use of CGM
• chronic oral steroid use.

Where it is running

• Icahn School of Medicine at Mount Sinai — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.